Keith A. Goldan, CFO of Syndax Pharmaceuticals ($SNDX), made one open market purchase of SNDX shares worth $0 in the last year, most recently on May 19, 2025. This ranks 4,939th out of 4,983 insiders by purchase value, well below the $1.5 million average over 3.3 transactions. He sold shares three times for about $127,000 total, most recently on February 9, 2026, ranking 9,225th among 11,678 insiders versus the $8.6 million average across 6.4 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 9, 2026 | Syndax Pharmaceuticals Inc | $SNDX | Goldan Keith A. | Chief Financial Officer | S | Common Stock | 3410 | $21.03 | 140,429.0000 | 86,914,838 | 2.37% | 0.00% |
| Feb. 4, 2026 | Syndax Pharmaceuticals Inc | $SNDX | Goldan Keith A. | Chief Financial Officer | A | Stock Options (Right to buy) | 118000 | $20.43 | 118,000.0000 | 86,914,838 | 9999.99% | 0.14% |
| Feb. 6, 2026 | Syndax Pharmaceuticals Inc | $SNDX | Goldan Keith A. | Chief Financial Officer | S | Common Stock | 2082 | $20.62 | 143,839.0000 | 86,914,838 | 1.43% | 0.00% |
| Jan. 30, 2026 | Syndax Pharmaceuticals Inc | $SNDX | Goldan Keith A. | Chief Financial Officer | J | Common Stock | 1219 | $8.48 | 93,671.0000 | 86,914,838 | 1.32% | 0.00% |
| Feb. 4, 2026 | Syndax Pharmaceuticals Inc | $SNDX | Goldan Keith A. | Chief Financial Officer | A | Common Stock | 30750 | $0.00 | 145,921.0000 | 86,914,838 | 26.70% | 0.04% |
| Feb. 4, 2026 | Syndax Pharmaceuticals Inc | $SNDX | Goldan Keith A. | Chief Financial Officer | A | Common Stock | 21500 | $0.00 | 115,171.0000 | 86,914,838 | 22.95% | 0.02% |
| Dec. 1, 2025 | Syndax Pharmaceuticals Inc | $SNDX | Goldan Keith A. | Chief Financial Officer | G | Common Stock | 1224 | $0.00 | 92,452.0000 | 86,914,838 | 1.31% | 0.00% |
| July 31, 2025 | Syndax Pharmaceuticals Inc | $SNDX | Goldan Keith A. | Chief Financial Officer | J | Common Stock | 1226 | $8.43 | 93,676.0000 | 86,024,394 | 1.33% | 0.00% |
| July 16, 2025 | Syndax Pharmaceuticals Inc | $SNDX | Goldan Keith A. | Chief Financial Officer | S | Common Stock | 1296 | $9.29 | 92,450.0000 | 86,024,394 | 1.38% | 0.00% |
| May 19, 2025 | Syndax Pharmaceuticals Inc | $SNDX | Goldan Keith A. | Chief Financial Officer | P | Common Stock | 3000 | $0.00 | 93,746.0000 | 86,024,394 | 3.31% | 0.00% |
| Feb. 10, 2025 | Syndax Pharmaceuticals Inc | $SNDX | Goldan Keith A. | Chief Financial Officer | S | Common Stock | 3777 | $15.50 | 90,746.0000 | 0 | 4.00% | 0.00% |
| Feb. 5, 2025 | Syndax Pharmaceuticals Inc | $SNDX | Goldan Keith A. | Chief Financial Officer | A | Stock Options (Right to buy) | 110500 | $14.65 | 110,500.0000 | 0 | 9999.99% | 0.00% |
| Feb. 5, 2025 | Syndax Pharmaceuticals Inc | $SNDX | Goldan Keith A. | Chief Financial Officer | A | Common Stock | 18500 | $0.00 | 71,123.0000 | 0 | 35.16% | 0.00% |
| Feb. 5, 2025 | Syndax Pharmaceuticals Inc | $SNDX | Goldan Keith A. | Chief Financial Officer | A | Common Stock | 23400 | $0.00 | 94,523.0000 | 0 | 32.90% | 0.00% |
| June 14, 2024 | Syndax Pharmaceuticals Inc | $SNDX | Goldan Keith A. | Chief Financial Officer | P | Common Stock | 1250 | $20.03 | 52,623.0000 | 0 | 2.43% | 0.00% |
| Feb. 7, 2024 | Syndax Pharmaceuticals Inc | $SNDX | Goldan Keith A. | Chief Financial Officer | A | Stock Options (Right to buy) | 70000 | $22.28 | 70,000.0000 | 0 | 9999.99% | 0.00% |
| Feb. 7, 2024 | Syndax Pharmaceuticals Inc | $SNDX | Goldan Keith A. | Chief Financial Officer | A | Common Stock | 35000 | $0.00 | 39,673.0000 | 0 | 748.98% | 0.00% |
| Jan. 31, 2024 | Syndax Pharmaceuticals Inc | $SNDX | Goldan Keith A. | Chief Financial Officer | J | Common Stock | 1183 | $17.42 | 4,673.0000 | 0 | 33.90% | 0.00% |
| July 31, 2023 | Syndax Pharmaceuticals Inc | $SNDX | Goldan Keith A. | Chief Financial Officer | J | Common Stock | 862 | $18.12 | 3,490.0000 | 0 | 32.80% | 0.00% |
| Feb. 7, 2024 | Syndax Pharmaceuticals Inc | $SNDX | Goldan Keith A. | Chief Financial Officer | A | Common Stock | 11700 | $0.00 | 51,373.0000 | 0 | 29.49% | 0.00% |
| June 13, 2023 | Syndax Pharmaceuticals Inc | $SNDX | Goldan Keith A. | Chief Financial Officer | S | Common Stock | 577 | $22.31 | 2,628.0000 | 0 | 18.00% | 0.00% |
| Feb. 2, 2023 | Syndax Pharmaceuticals Inc | $SNDX | Goldan Keith A. | Chief Financial Officer | A | Stock Options (Right to buy) | 110000 | $28.55 | 110,000.0000 | 0 | 9999.99% | 0.00% |